14. Yen HL, Lipatov AS, Ilyushina NA. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J Virol 2007; 81:6890–6898.
15. Van Riel D, Munster VJ, de Wit E. H5N1 virus attachment to lower respiratory tract. Science 2006; 312:99.
16. Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009; 45:169–73.
17. Coburn BJ, Wagner BG, Blower S. Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Med 2009; 7:30.
18. Viboud C, Tam T, Fleming D. Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine 2006; 24:6701–07.
19. Chowell G, Bertozzi SM, Colchero MA. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009; 361:674–9.
20. Lipsitch M, Riley S, Cauchemez S. Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med 2009; 361:112–5.
21. Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:536–541.
22. Jain S, Kamimoto L, Bramley AM. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935–44.
23. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361:680–9.
24. World Health Organization (WHO). Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009. Wkly Epidemiol Rec 2009; 84:237–44.
25. Dominguez-Cherit G, Lapinsky SE, Macias AE. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302:1880–7.
26. Kumar A, Zarychanski R, Pinto R. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302:1872–9.
27. White DB, Angus DC. Preparing for the sickest patients with 2009 influenza A(H1N1). JAMA 2009; 302:1905–6.
28. Davies A, Jones D, Bailey M. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009; 302:1888–95.
29. Webb SA, Pettila V, Seppelt I. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361:1925–34.
30. Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918–19 influenza pandemic. Emerg Infect Dis 2008; 14:1193–9.
31. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962–70.
32. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1071–1074.
33. Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009; 58:749–752.
34. Centers for Disease Control and Prevention (CDC). Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009. MMWR Morb Mortal Wkly Rep 2009; 58:497–500.
35. Jamieson DJ, Honein MA, Rasmussen SA. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451–8.
36. Vaillant L, La Ruche G, Tarantola A. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009; 14:1–6.
37. Centers for Disease Control and Prevention (CDC). Persons for whom annual vaccination is recommended. Accesible en;
http://www.cdc.gov/flu/professionals/acip/persons.htm. Último acceso 2 Noviembre 2011.
38. World Health Organization (WHO). Vaccines for pandemic influenza A (H1N1). Accesible en;
http://www.who.int/csr/disease/swineflu/frequently_asked_questions/vaccine_preparedness/en/. Último acceso 2 Noviembre 2011.
39. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis – North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:969–972.
40. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:893–6.
41. World Health Organization (WHO). Guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Accesible en;
http://www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf.
Último acceso 2 Noviembre 2011.
42. Tang W J; Shetty N; Tsan-Yuk Lam T. Features of the New Pandemic Influenza A/H1N1/2009 Virus: Virology, Epidemiology, Clinical and Public Health Aspects. Curr Opin Pulm Med. 2010;16(3):235-41.
43. Singer AC, Howard BM, Johnson AC. Meeting report: risk assessment of Tamiflu use under pandemic conditions. Environ Health Perspect 2008; 116:1563–7.
44. Singer AC, Johnson AC, Anderson PD. Reassessing the risks of Tamiflu use during a pandemic to the Lower Colorado River. Environ Health Perspect 2008; 116:A285–A286.
45. Singer AC, Nunn MA, Gould EA. Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect 2007; 115:102–6.
46. Centers for Disease Control and Prevention (CDC). Three reports of oseltamivir resistant novel influenza A (H1N1) viruses. Accesible en
http://www.cdc.gov/h1n1flu/HAN/070909.htm.
Último acceso 2 Noviembre 20011.
47. Birnkrant D, Cox E. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 2009; 361:2204–7.
48. Centers for Disease Control and Prevention (CDC). Emergency use authorization of peramivir IV. Accesible en; http://www.cdc.gov/h1n1flu/eua/peramivir.htm. Último acceso 2 Noviembre 2011.
49. Hancock K, Veguilla V, Lu X. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945–52.
50. Chen H, Wang Y, Liu W. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis 2009; 15:1849–1850.
51. Greenbaum JA, Kotturi MF, Kim Y. Preexisting immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 2009; 106:20365–70.
52. Clark TW, Pareek M, Hoschler K. Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine – preliminary report. N Engl J Med 2009; 361:2424–35.
53. Greenberg ME, Lai MH, Hartel GF. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine – preliminary report. N Engl J Med 2009. doi: 10.1056/NEJMoa0907413 2009.
54. Centers for Disease Control and Prevention (CDC). Allocation and distribution Q&A. Accesible en;
http://www.cdc.gov/H1N1flu/vaccination/statelocal/centralized_distribution_qa.htm.
Último acceso 2 November 2011.
55. Centers for Disease Control and Prevention (CDC). Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 2009; 84:185–9.
56. Cauchemez S, Ferguson NM, Wachtel C. Closure of schools during an influenza pandemic. Lancet Infect Dis 2009; 9:473–81.
57. Centers for Disease Control and Prevention (CDC). Update on school (k-12) and child care programs: interim CDC guidance in response to human infections with the novel influenza A (H1N1) virus. Accesible en; http://www.cdc.gov/H1N1flu/k12_dismissal.htm. Último acceso 12 Noviembre 2011.
58. Sypsa V, Hatzakis A. School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modeling study. Euro Surveill 2009; 14:1–7.
59. Jefferson T, Del Mar C, Dooley L. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ 2009; 339:b3675.
60. Srinivasan A, Perl TM. Respiratory protection against influenza. JAMA 2009; 302:1903–4.
61. Loeb M, Dafoe N, Mahony J. Surgical mask vs N95 respirator for preventing influenza among healthcare workers: a randomized trial. JAMA 2009; 302:1865–71.
62. Cowling BJ, Chan KH, Fang VJ. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med 2009; 151:437–46.